An in vitro study on B cells isolated from SSc patients and healthy donors reported significantly reduced IL-10 production when the SSc B cells were stimulated via TLR9 perhaps indicating defective TLR9 signalling in the B cells from SSc patients (18). This evidence concerns the gene IL10 and systemic sclerosis.